Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Streptococcus pneumonia remains the most common bacterial cause, while viral infections such as influenza, COVID-19, and respiratory syncytial virus (RSV) are particularly common during the winter ...

Many Northern Hemisphere countries have an increase in acute respiratory infections during this time of year. These increases are usually driven by seasonal epidemics of respiratory infections ...

According to China CDC data, the pathogens causing these infections are known ones, and they include the seasonal influenza virus, RSV (respiratory syncytial virus), HMPV, and SARS-CoV-2 (the ...

Paul Hunter consults for the World Health Organization. He receives funding from National Institute for Health Research and has received funding from the World Health Organization and the European ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

The CDC monitors RSV through the Respiratory Syncytial Virus Hospitalization Surveillance ... RSV treatments for adults are mostly self-care, as infections tend to go away on their own.

“Co-infections with other viruses like RSV (Respiratory syncytial virus) or bacteria may also exacerbate the severity of the disease." Constant monitoring of respiratory symptoms in infants and ...